We are live on ! Find out more
CCM

Cinctive Capital Management Portfolio holdings

AUM $1.53B
1-Year Est. Return 48.83%
This Fund
S&P 500
This Quarter Est. Return
+11.37%
1 Year Est. Return
+48.83%
3 Year Est. Return
+143.95%
5 Year Est. Return
+199.46%
10 Year Est. Return
AUM
$2.09B
AUM Growth
+$200M
Cap. Flow
+$51.2M
Cap. Flow %
2.45%
Top 10 Hldgs %
13.97%
Holding
550
New
196
Increased
89
Reduced
103
Closed
157

Top Buys

Rank Stock Value
1
CYBR
CyberArk
CYBR
+$28.2M
2
YUM icon
Yum! Brands
YUM
+$20.8M
3
TXRH icon
Texas Roadhouse
TXRH
+$20.1M
4
HUBS icon
HubSpot
HUBS
+$20M
5
ROST icon
Ross Stores
ROST
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 15.58%
3 Consumer Discretionary 14.04%
4 Financials 11.38%
5 Industrials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPRE icon
251
Green Plains
GPRE
$1.15B
$1.98M 0.09%
+225,055
New +$1.97M
CME icon
252
CME Group
CME
$95.4B
$1.98M 0.09%
+7,318
New +$1.99M
HESM icon
253
Hess Midstream
HESM
$5.22B
$1.98M 0.09%
+57,215
New +$2.27M
UNH icon
254
UnitedHealth
UNH
$378B
$1.96M 0.09%
+5,689
New +$1.72M
MCO icon
255
Moody's
MCO
$83.3B
$1.93M 0.09%
+4,060
New +$2.05M
AM icon
256
Antero Midstream
AM
$10.4B
$1.93M 0.09%
99,319
-260,008
-72% -$4.7M
FORM icon
257
FormFactor
FORM
$8.57B
$1.92M 0.09%
+52,830
New +$1.7M
BEN icon
258
Franklin Resources
BEN
$18.1B
$1.87M 0.09%
81,033
-88,541
-52% -$2.19M
EZU icon
259
iShare MSCI Eurozone ETF
EZU
$9.72B
$1.86M 0.09%
+30,000
New +$1.8M
JBTM
260
JBT Marel
JBTM
$7.35B
$1.85M 0.09%
13,139
-12,928
-50% -$1.77M
ALAB icon
261
Astera Labs
ALAB
$56.3B
$1.84M 0.09%
+9,409
New +$1.55M
AHL
262
DELISTED
Aspen Insurance
AHL
$1.84M 0.09%
+50,000
New +$1.64M
NXE icon
263
NexGen Energy
NXE
$6.35B
$1.83M 0.09%
204,088
-627,587
-75% -$4.63M
SEE
264
CALL
DELISTED
Sealed Air
SEE
$1.77M 0.08%
+50,000
New +$1.59M
NRIX icon
265
Nurix Therapeutics
NRIX
$2.4B
$1.76M 0.08%
191,015
+74,882
+64% +$778K
HLI icon
266
Houlihan Lokey
HLI
$8.55B
$1.75M 0.08%
+8,517
New +$1.67M
VIK icon
267
Viking Holdings
VIK
$47.6B
$1.72M 0.08%
+27,620
New +$1.65M
RMBS icon
268
Rambus
RMBS
$10.1B
$1.7M 0.08%
16,315
-49,362
-75% -$3.81M
ASND icon
269
Ascendis Pharma A/S
ASND
$16.1B
$1.67M 0.08%
8,376
-838
-9% -$156K
MDGL icon
270
Madrigal Pharmaceuticals
MDGL
$10.9B
$1.65M 0.08%
3,606
-1,162
-24% -$434K
COGT icon
271
Cogent Biosciences
COGT
$6.67B
$1.59M 0.08%
+111,058
New +$1.32M
KKR icon
272
KKR & Co
KKR
$94.5B
$1.58M 0.08%
12,126
-32,165
-73% -$4.57M
PEN icon
273
Penumbra
PEN
$12.7B
$1.57M 0.08%
+6,215
New +$1.57M
BLDR icon
274
Builders FirstSource
BLDR
$7.76B
$1.56M 0.07%
12,869
-66,865
-84% -$8.87M
AKRO
275
DELISTED
Akero Therapeutics
AKRO
$1.51M 0.07%
+31,903
New +$1.54M

Similar funds

Cinctive Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Cinctive Capital Management held 550 positions worth $2.09B, up 11% from $1.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Cinctive Capital Management's Q3 2025 filing shows 196 new, 89 increased, 103 reduced and 157 closed positions. Its largest new stake was Yum! Brands: 141,561 shares worth $21.5M. The largest sale was Blueprint Medicines, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Cinctive Capital Management's largest Q3 2025 buy was Yum! Brands: 141,561 shares worth $21.5M.
  • Cinctive Capital Management added most to CyberArk in Q3 2025, an estimated $28.2M increase.
  • Cinctive Capital Management's biggest Q3 2025 reduction was Bloom Energy, cutting an estimated $30M.
  • Cinctive Capital Management fully exited Blueprint Medicines in Q3 2025, selling an estimated $34M.
  • Cinctive Capital Management's ten largest holdings make up 14% of its $2.09B portfolio in Q3 2025.
  • Cinctive Capital Management opened 196 new positions and closed 157 in Q3 2025.
  • Cinctive Capital Management's portfolio value rose 11% quarter-over-quarter to $2.09B.

Based on Cinctive Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.